Tascom Co (XKRX:336040) Cash-to-Debt : 0.00 (As of . 20)

View and export this data going back to 2019. Start your Free Trial

What is Tascom Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Tascom Co's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Tascom Co couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Tascom Co's Cash-to-Debt or its related term are showing as below:

XKRX:336040's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.97
* Ranked among companies with meaningful Cash-to-Debt only.

Tascom Co Cash-to-Debt Historical Data

The historical data trend for Tascom Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Tascom Co Cash-to-Debt Chart

Tascom Co Annual Data

Trend

Cash-to-Debt

Tascom Co Semi-Annual Data

Cash-to-Debt

Competitive Comparison of Tascom Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Tascom Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tascom Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tascom Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Tascom Co's Cash-to-Debt falls into.

Tascom Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Tascom Co's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Tascom Co's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Tascom Co (XKRX:336040) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Tascom Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Tascom Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tascom Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

43 BanPo-daero 28-gil, 5th Floor, i-SENS Building, SeoCho-gu, Seoul, KOR

Website

http://www.yidobio.com

Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.

Tascom Co Headlines

No Headlines